chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nurse did a double dose (1ml) in error; A spontaneous report was received from a nurse concerning a 62-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and resulting in the event of inappropriate dose administered.  There were no medical history and concomitant medications reported.  On 06 JAN 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 025L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 06 JAN 2021, the nurse gave the patient a double dose (1 ml) of the vaccine. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, "inappropriate dose administered" was considered resolved on 06 JAN 2021.; Reporter's Comments: This case concerns a 62-year-old, male patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Incorrect dose administered.
On 5/15/17, child seen for nurse to give Hep B vaccine (vaccine ordered 5/1/17 by MD). Nurse accidentally gave Hep A vaccine. Mild congestion reported by mom 6/5/17 - but no fever, no rash, no irritability/crying, local RXN at injection site. Child's hx and exam all benign on 6/24/17. Mistake by LPN discovered when lot # checked. No adverse RXN noted from vaccine administration error.
Patient arrives from vaccines site, having a witnessed seizure after receiving Covid -19 vaccine injection. Patient has no previous history of seizures.
Sore site on injection,   All joint and muscles ache - took Aleve and bedrest.   Migraine for two days.   NOTE: this reaction started two days after the injection.
Site: Pain at Injection Site-Severe, Additional Details: Patient is complaining of severe pain radiating from the left neck down to the injection site. Patient claims it started two days after getting the vaccine and has not went away since.
Pt wife reported syncope while driving about 20-30 minutes after leaving the store. She states he woke from fainting upon impact with another car.  Do not know if pt will seek further treatment at this time.
pain on the left side of my chest; feel like I have the flu; fast heart rate; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain on the left side of my chest), INFLUENZA LIKE ILLNESS (feel like I have the flu) and HEART RATE INCREASED (fast heart rate) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 07-Oct-2023, the patient experienced CHEST PAIN (pain on the left side of my chest), INFLUENZA LIKE ILLNESS (feel like I have the flu) and HEART RATE INCREASED (fast heart rate). At the time of the report, CHEST PAIN (pain on the left side of my chest), INFLUENZA LIKE ILLNESS (feel like I have the flu) and HEART RATE INCREASED (fast heart rate) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: At rest 60-99.     For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.  Patient got vaccinated with latest vaccine. In the morning patient woke up with pain on the left side of chest and had fast heart rate. The pain was like a 4 to 5 and heart rate at rest was 60 to 99.   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2023: Live follow-up received with NNI
Rec'd 2 Imovax immunizations as post-exposure prophylaxis in a ED.  At the third visit to the ED (6/16/07) was given Rabavert. On 6/17 he became fussy, refusing to take solid foods. On 6/21 he had a fever to 38.4 with lethargy and fatigue.  On 6/22 he developed a blotchy generalized rash.  On 6/23 he presented to our ED with worsening fussiness, new petichiae and incosolability.  Work up was negative (LP, blood culture), was given ceftriaxone and dose #4 of rabies vaccine Imovax.  On 6/25 he no longer had a rash or fever, was taking POs and nearly back to baseline.
15 Year old male inadvertently administered 1st dose of Moderna Covid 19 vaccine to a person under the age of 18.
Fever, tiredness, arm soreness, headache, and body aches. Did not seek medical attention, self treated with Tylenol and rest. Lasted 3 days. Got COVID-19 in Nov.. Reached out to doctor, was able to receive antibody therapy 3 days after diagnosis, cold symptoms, fever, tiredness, nausea, loss of taste and smell.
1 of 3 pts vaxed from the same lot# exp an inject site react which included redness, swelling & soreness; react lasted approx 4 days; No treatment given; pt recovered;
Patient describes adverse event as pain in left portion of the chest accompanied by numbness going down the patients left arm down to the hand. Stiffness in the neck has been noted during the event.
Right arm where injection administered red, hot, hard spot, swollen, itches, painful to touch.
4/6/2023 I started having congestion and a mild cough. I thought it was a cold or allergies. It progressed for two weeks with cough. 4/19/23 I did not have a fever but had a chest congestion. I saw the doctor on 4/21/23. Chest X-ray pneumonia on right lung. They gave me levofloxacin. I had a low grade fever about 100 on 20APR23.
Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months; Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months; The vaccine was administered after being diluted by the Pfizer COVID-19 vaccine diluent, 2.2 mL of 0.9% sodium chloride (normal saline, preservative free) of the diluent used for Pfizer COVID-19 vaccine into the bottle of magenta border Moderna; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months), ACCIDENTAL UNDERDOSE (Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months) and PRODUCT PREPARATION ERROR (The vaccine was administered after being diluted by the Pfizer COVID-19 vaccine diluent, 2.2 mL of 0.9% sodium chloride (normal saline, preservative free) of the diluent used for Pfizer COVID-19 vaccine into the bottle of magenta border Moderna) in a 5-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .2 milliliter. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months), ACCIDENTAL UNDERDOSE (Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months) and PRODUCT PREPARATION ERROR (The vaccine was administered after being diluted by the Pfizer COVID-19 vaccine diluent, 2.2 mL of 0.9% sodium chloride (normal saline, preservative free) of the diluent used for Pfizer COVID-19 vaccine into the bottle of magenta border Moderna). At the time of the report, INCORRECT DOSE ADMINISTERED (Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months), ACCIDENTAL UNDERDOSE (Vaccine with 0.2 mL dose was administered to 1 child that was 5 years and 2 months) and PRODUCT PREPARATION ERROR (The vaccine was administered after being diluted by the Pfizer COVID-19 vaccine diluent, 2.2 mL of 0.9% sodium chloride (normal saline, preservative free) of the diluent used for Pfizer COVID-19 vaccine into the bottle of magenta border Moderna) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was 5 years and 2 months old. No concomitant medications were provided by the reporter. The parents stated no side effects or adverse reactions post vaccination. No treatment medications were provided by the reporter.   This case was linked to MOD-2022-604280 (Patient Link).
On 10/27/01 pt had a 10 minute febrile seizure and on presentation to the local ER he had a temperature of 104.7 and shortly thereafter developed a papular rash. Laboratory evaluation was performed and he was referred to local pediatrician for follow up. No previous history of febrile seizures.
High temp (104) three febrile seizures, localized the left side of body. Diagnosed with post infectious cerebellitis. Was not able to walk for 6 days.
Pt was given MENACTRA at office visit. Came in 24 hours later with redness, swelling at site.
Injection site arm is sore; A spontaneous report was received from a health care professional concerning a 69-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed pain at vaccination site.    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, was not provided.     On 04 Mar 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot 032M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.      On unknown date, the patient developed pain at injection site  Treatment for the event was not provided.     Action taken with mRNA-1273 in response to the event was unknown.      The outcome of the event, pain at vaccination site was considered unknown.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 18Jul2021 17:15 (Lot number: EW0198) at the age of 34 years as dose number unknown, single for Covid-19 immunisation. Relevant medical history included: "Neurocardiogenic Syncope" (unspecified if ongoing), notes: Verbatim: Neurocardiogenic Syncope. Concomitant medication(s) included: Pristiq; Adderall; Fludrocortisone; Meloxicam. The following information was reported: FATIGUE (non-serious) with onset 18Jul2021 21:00, outcome "not recovered", described as "Fatigue extreme"; ASTHENIA (non-serious) with onset 18Jul2021 21:00, outcome "not recovered", described as "lack of energy since injection"; TINNITUS (non-serious) with onset 18Jul2021 21:00, outcome "not recovered", described as "tinnitus left ear"; EAR DISCOMFORT (non-serious) with onset 18Jul2021 21:00, outcome "not recovered", described as "fluttering sound in ear"; VACCINATION SITE PAIN (non-serious) with onset 18Jul2021 21:00, outcome "not recovered", described as "sore arm/muscle injection site". Therapeutic measures were not taken as a result of fatigue, asthenia, tinnitus, ear discomfort, vaccination site pain. Additional Information: Facility type for vaccine reported as pharmacy or drug store. No other vaccine in four weeks. Patient had no Covid-19 prior vaccination. Patient was not tested Covid-19 post vaccination. No known allergies reported. Follow-up attempts are completed. No further information is expected.
Facial flushing within 15 minutes, went away after 30 minutes.; Facial puffiness within 15 minutes, went away after 30 minutes.; Arm got swollen later in the day; Arm got swollen and very warm later in the day; itchy later in the day; Experienced Fatigue off and on for 6 days after; Experienced brain fog off and on for 6 days after; Experienced 101 fever off and on 6 days after; temporary loss of taste off and on for 6 days after; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0164) via an unspecified route of administration in the left arm on 19Apr2021 at 13:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety, high blood pressure, allergies to diary and sulfa. It was unknown, whether the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received amoxicillin/ clavulanic acid (AUGMENTIN) for an unknown indication on an unknown date and experienced drug allergy. On 19Apr2021 at 13:45 within 15 minutes, the patient experienced facial flushing and puffiness which went away after 30 minutes. Arm got swollen, very warm and itchy later in the day. On the same day, the patient also experienced fatigue, brain fog, 101 fever and temporary loss of taste off and on for 6 days after. On 19Apr2021, the patient underwent lab tests and procedures which included body temperature test and the result was found to be 101 (unspecified units). The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events facial flushing, puffiness within 15 minutes were recovered on an unknown date in Apr2021 after 30 minutes, while the events fatigue, brain fog, 101 fever and temporary loss of taste off and on were recovered on an unknown date in Apr2021 after 6 days and the events arm got swollen, very warm and itchy later in the day were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 29-DEC-2014, a pharmacist administered ZOSTAVAX, (lot# and route unknown) to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In December 2015, the patient was treated by a healthcare provider for shingles.  The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
pt began coughing, complaining of scratchy throat, tongue became swollen and pt had difficulty swallowing
The normal stuff that they say would happen happened and it was pretty severe but then my symptoms started up again on 4/25 in the morning and they just frequently come and go so I went to get another Covid test to make sure I didn't have covid-19 . The symptoms of
My son was extremely tired after getting shots I had to wake him to feed him the next morning he passed away.
Patient took moderna#2 on 4/17/2021, reported severe side effects for 5 days - achiness, fatigue, fever, dizziness. also testicular swelling which was unexpected. now resolved.
I got a screening because I was having a procedure done and the test was a requirement. I had absolutely no symptoms at all.
He had just gotten over the COVID-19 virus; He had a" flu" case; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA (He had a" flu" case) and COVID-19 (He had just gotten over the COVID-19 virus) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jun-2022, the patient experienced COVID-19 (He had just gotten over the COVID-19 virus). On an unknown date, the patient experienced INFLUENZA (He had a" flu" case). At the time of the report, INFLUENZA (He had a" flu" case) and COVID-19 (He had just gotten over the COVID-19 virus) had resolved.            No concomitant medications were provided. No treatment information was reported.  Lot number and expiration dates not provided. The dates of administration for patient's other Moderna vaccines was not provided.  Company Comment:  This spontaneous case concerns an adult male patient of unspecified age, with no reported medical history, who experienced the unexpected, non-serious adverse event of special interest COVID-19 (reported as He had just gotten over the COVID-19 virus) on an unknown interval (date of vaccination unknown) after receiving a dose of mRNA-1273 vaccine.  Information on treatment or SARS-CoV-2 test was not provided.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2022-609254 (Patient Link).; Sender's Comments: This spontaneous case concerns an adult male patient of unspecified age, with no reported medical history, who experienced the unexpected, non-serious adverse event of special interest COVID-19 (reported as He had just gotten over the COVID-19 virus) on an unknown interval (date of vaccination unknown) after receiving a dose of mRNA-1273 vaccine.  Information on treatment or SARS-CoV-2 test was not provided.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
This spontaneous report was received from a pharmacist and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates since 03-NOV-2013, the patients were vaccinated with 19 improperly stored doses of ZOSTAVAX lot# J006832, expiration date 14-SEP-2014 (dose and route of administration were not reported). There was no adverse effect reported. Data logger was not involved. There were no information about previous excursions reported. This is one of two reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1703USA007724:
Information has been received from a physician concerning a 1 year old patient who on 08-JUN-2007 was vaccinated subcutaneously with a 0.65 ml dose of Zostavax (Oka/Merck).  There were no symptoms noted.  No further information was provided.  There was no product quality complaint involved.  Follow up information was received from the physician who said that the patient was supposed to receive a dose of ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) (MSD) instead of Zostavax (Oka/Merck).  "A staff member at the office though they had a ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) vial out of the box in the freezer, but instead a vial of Zostavax (Oka/Merck) had been put in the ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) (MSD) box by mistake.  The staff member realized the mistake after the vaccine had been administered, when they were recording the information in their vaccine records.  It was an oversight by the office and the office was instructed on proper vaccine storage and replacing the vials in their proper places."  The physician called the patient a week later and there had been no problems.  No further information is expected.
Pain and redness at the injection site, nausea, vomiting/diarrhea, fever, inflammation.
Intense chills and sweats; Multiple body aches including joint pain and headache; Multiple body aches including joint pain and headache; Multiple body aches including joint pain and headache; Restless sleep; Frequent urination; Intense chills and sweats; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number:1686 (as reported)), via an unspecified route of administration on 05Jan2021 at 13:00 at single dose in left arm for COVID-19 immunisation. Age at vaccination was 54 years. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient has no allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. On 05Jan2021 at 21:00 the patient experienced intense chills and sweats, multiple body aches including joint pain and headache, restless sleep and frequent urination. These symptoms started approximately 12 hours after injection (clarification requested) and lasted for approximately 14-16 hours. The events were non serious. No treatment was received for the events. The events resolved in Jan2021. Since the vaccination, the patient has not been tested for COVID-19.
Pt fainted after vaccination. this is the first time after a shot.  no meds administered, was fine after a few minutes.